文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

意大利 65 岁以下新冠肺炎死亡成年人的肥胖和代谢异常因素:一项回顾性病例对照研究。

Obesity and Dysmetabolic Factors among Deceased COVID-19 Adults under 65 Years of Age in Italy: A Retrospective Case-Control Study.

机构信息

Center for Global Health, Istituto Superiore di Sanità, 00161 Rome, Italy.

Hepatology Unit, San Giuseppe Hospital, 20123 Milan, Italy.

出版信息

Viruses. 2022 Sep 7;14(9):1981. doi: 10.3390/v14091981.


DOI:10.3390/v14091981
PMID:36146787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9504992/
Abstract

BACKGROUND: Italy has witnessed high levels of COVID-19 deaths, mainly at the elderly age. We assessed the comorbidity and the biochemical profiles of consecutive patients ≤65 years of age to identify a potential risk profile for death. METHODS: We retrospectively analyzed clinical data from consecutive hospitalized-for-COVID-19 patients ≤65 years, who were died (593 patients) or discharged (912 patients) during February-December 2020. Multivariate logistic regression identified the mortality risk factors. RESULTS: Overweight (adjusted odds ratio (adjOR) 5.53, 95% CI 2.07-14.76), obesity (adjOR 8.58, CI 3.30-22.29), dyslipidemia (adjOR 10.02, 95% CI 1.06-94.22), heart disease (adjOR 17.68, 95% CI 3.80-82.18), cancer (adjOR 13.28, 95% CI 4.25-41.51) and male sex (adjOR 5.24, 95% CI 2.30-11.94) were associated with death risk in the youngest population. In the older population (46-65 years of age), the overweight and obesity were also associated with the death risk, however at a lower extent: the adjORs varyied from 1.49 to 2.36 for overweight patients and from 3.00 to 4.07 for obese patients. Diabetes was independently associated with death only in these older patients. CONCLUSION: Overweight, obesity and dyslipidemia had a pivotal role in increasing young individuals' death risk. Their presence should be carefully evaluated for prevention and/or prompt management of SARS-CoV2 infection in such high-risk patients to avoid the worst outcomes.

摘要

背景:意大利的 COVID-19 死亡率较高,主要发生在老年人群中。我们评估了连续≤65 岁住院 COVID-19 患者的合并症和生化特征,以确定死亡的潜在风险特征。

方法:我们回顾性分析了 2020 年 2 月至 12 月连续住院的≤65 岁 COVID-19 患者的临床数据,这些患者死亡(593 例)或出院(912 例)。多变量逻辑回归确定了死亡的危险因素。

结果:超重(调整后的优势比(adjOR)5.53,95%可信区间 2.07-14.76)、肥胖(adjOR 8.58,95%可信区间 3.30-22.29)、血脂异常(adjOR 10.02,95%可信区间 1.06-94.22)、心脏病(adjOR 17.68,95%可信区间 3.80-82.18)、癌症(adjOR 13.28,95%可信区间 4.25-41.51)和男性(adjOR 5.24,95%可信区间 2.30-11.94)与最年轻人群的死亡风险相关。在年龄较大的人群(46-65 岁)中,超重和肥胖也与死亡风险相关,但程度较低:超重患者的 adjOR 从 1.49 到 2.36 不等,肥胖患者的 adjOR 从 3.00 到 4.07 不等。糖尿病仅与这些老年患者的死亡相关。

结论:超重、肥胖和血脂异常在增加年轻个体的死亡风险方面起着关键作用。在这些高风险患者中,应仔细评估其存在情况,以预防和/或及时管理 SARS-CoV2 感染,避免最坏的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e2/9504992/1a6acf9f26c8/viruses-14-01981-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e2/9504992/a91f01224567/viruses-14-01981-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e2/9504992/1a6acf9f26c8/viruses-14-01981-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e2/9504992/a91f01224567/viruses-14-01981-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33e2/9504992/1a6acf9f26c8/viruses-14-01981-g002.jpg

相似文献

[1]
Obesity and Dysmetabolic Factors among Deceased COVID-19 Adults under 65 Years of Age in Italy: A Retrospective Case-Control Study.

Viruses. 2022-9-7

[2]
Geriatrics-focused indicators predict mortality more than age in older adults hospitalized with COVID-19.

BMC Geriatr. 2021-10-14

[3]
Diabetes and Overweight/Obesity Are Independent, Nonadditive Risk Factors for In-Hospital Severity of COVID-19: An International, Multicenter Retrospective Meta-analysis.

Diabetes Care. 2021-6

[4]
Excess body weight is an independent risk factor for severe forms of COVID-19.

Metabolism. 2021-4

[5]
Nonrespiratory Complications and Obesity in Patients Dying with COVID-19 in Italy.

Obesity (Silver Spring). 2021-1

[6]
Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.

Diabetes Care. 2020-5-14

[7]
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.

JAMA. 2020-4-28

[8]
Comorbidity status of deceased COVID-19 in-patients in Italy.

Aging Clin Exp Res. 2021-8

[9]
The association between BMI and metabolically unhealthy status with COVID-19 mortality: Based on 3019 inpatients from Wuhan, China.

Nutr Metab Cardiovasc Dis. 2021-10-28

[10]
Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry.

Circulation. 2021-1-12

引用本文的文献

[1]
Impaired inflammatory resolution with severe SARS-CoV-2 infection in leptin knock out obese hamster.

iScience. 2025-1-17

[2]
Aeroallergen immunotherapy associated with reduced risk of severe COVID-19 in 1095 allergic patients.

World Allergy Organ J. 2023-5

[3]
Retrospective Analysis of the Outcome of Hospitalized COVID-19 Patients with Coexisting Metabolic Syndrome and HIV Using Multinomial Logistic Regression.

Int J Environ Res Public Health. 2023-5-12

[4]
Safety and immunogenicity of inactivated COVID-19 vaccine in patients with metabolic syndrome: A cross-sectional observational study.

Front Public Health. 2022

本文引用的文献

[1]
Diabetes Increases Severe COVID-19 Outcomes Primarily in Younger Adults.

J Clin Endocrinol Metab. 2021-8-18

[2]
Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study.

Lancet Diabetes Endocrinol. 2021-6

[3]
Body Mass Index and Risk for COVID-19-Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death - United States, March-December 2020.

MMWR Morb Mortal Wkly Rep. 2021-3-12

[4]
Coronavirus Disease 2019 Hospitalizations Attributable to Cardiometabolic Conditions in the United States: A Comparative Risk Assessment Analysis.

J Am Heart Assoc. 2021-2

[5]
Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis.

Rev Endocr Metab Disord. 2021-6

[6]
Differences in the clinical characteristics of COVID-19 patients who died in hospital during different phases of the pandemic: national data from Italy.

Aging Clin Exp Res. 2021-1

[7]
COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes.

Diabetes Care. 2021-2

[8]
Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization.

Ann Intern Med. 2020-8-12

[9]
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre.

Eur J Endocrinol. 2020-10

[10]
Clinical Characteristics of Hospitalized Individuals Dying With COVID-19 by Age Group in Italy.

J Gerontol A Biol Sci Med Sci. 2020-9-16

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索